Fig. 7From: Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFRSchematic illustration of the functional roles of Kremen2 in promoting activation of the EGFR signaling pathways by increasing the stability of the EGFR protein and promoting the malignant progression of NSCLCBack to article page